Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts
Novo Nordisk A/S (NYSE:NVO) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 29,821 | $35,768,202 | -25% | 9.62% |
| 2. | Bourgeon Capital John Zaro | 24,426 | $29,296,920 | +5% | 4.31% |
| 3. | Lee Munder Capital Group Lee Munder | 20,478 | $24,561,928 | -3% | 1.32% |
| 4. | Ayrshire Capital Management John Nevin Jr. | 6,630 | $7,951,866 | -2% | 3.72% |
| 5. | RiverPark Advisors Mitch Rubin | 3,298 | $3,955,720 | -5% | 1.81% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing | |
| $996.18 | 2,208 | $2,199,572.06 | 91,881,150 | 2026-05-06 | Filing | |
| $995.23 | 13,620 | $13,554,964.50 | 91,883,358 | 2026-05-06 | Filing | |
| $1,116.69 | 2,737 | $3,056,369.58 | 91,896,978 | 2026-01-07 | Filing | |
| $1,115.76 | 2,210 | $2,465,831.81 | 91,899,715 | 2026-01-07 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,376,978 | $108,400,858,723 | 100% | |
| 2. | 1,781,310 | $2,136,556,652 | 1.84% | |
| 3. | 1,447,540 | $1,736,223,301 | 22.72% | |
| 4. | 758,740 | $910,055,515 | 1.12% | |
| 5. | 605,458 | $726,204,488 | 14.45% |